USA - New York Stock Exchange - NYSE:CNK - US17243V1026 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to CNK. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-21 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-09 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-04 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2025-08-04 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-04 | Roth Capital | Maintains | Buy -> Buy |
| 2025-07-11 | Wedbush | Upgrade | Neutral -> Outperform |
| 2025-07-10 | Deutsche Bank | Initiate | Buy |
| 2025-07-09 | Roth Capital | Maintains | Buy -> Buy |
| 2025-07-02 | Benchmark | Reiterate | Buy -> Buy |
| 2025-05-05 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-05-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-28 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-04-11 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-02-20 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-02-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-02-20 | Benchmark | Maintains | Buy -> Buy |
| 2025-02-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-02-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-02-19 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-30 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-01-29 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-01-10 | Benchmark | Reiterate | Buy -> Buy |
| 2024-12-03 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-04 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-01 | Macquarie | Maintains | Outperform -> Outperform |
| 2024-11-01 | Wedbush | Downgrade | Outperform -> Neutral |
| 2024-11-01 | Wells Fargo | Maintains | Overweight -> Overweight |
17 analysts have analysed CNK and the average price target is 34.84 USD. This implies a price increase of 27.23% is expected in the next year compared to the current price of 27.38.
The consensus rating for CINEMARK HOLDINGS INC (CNK) is 77.6471 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering CINEMARK HOLDINGS INC (CNK) is 17.